#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13812	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2573	655.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1964	1964	T	929	T,G,C,A	924,3,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13812	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2573	655.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1698	1698	C	873	C,T	872,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23870	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3935	755.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1861	1861	A	970	A	970	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23870	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3935	755.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2495	2495	C	799	C,T,A	797,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23870	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3935	755.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3121	3121	T	875	T,G	874,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23870	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3935	755.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2569	2569	A	736	A,C	734,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	G5V	NONSYN	13	15	GGT	487	489	GTT	131;129;128	G;T;T	131;129;128	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	E12K	NONSYN	34	36	GAA	508	510	AAA	144;144;147	A;A;A	144;144;147	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	F31L	NONSYN	91	93	TTT	565	567	TTG	192;193;192	T;T;G	192;193;192	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	598	600	CAA	213;215;215	C,A;A;A,G	212,1;215;214,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	S75P	NONSYN	223	225	TCC	697	699	CCT	163;168;170	C;C,A;T	163;166,2;170	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	V87A	NONSYN	259	261	GTA	733	735	GCA	147;142;140	G;C;A	147;142;140	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	V130L	NONSYN	388	390	GTC	862	864	CTC	196;196;195	C,A;T,G;C,T	195,1;195,1;194,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	R135C	NONSYN	403	405	CGC	877	879	TGT	202;205;209	T;G;T	202;205;209	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	T137A	NONSYN	409	411	ACG	883	885	GCG	214;212;210	G;C;G,T	214;212;209,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	925	927	AAG	245;241;242	A;A,C;G	245;240,1;242	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	T152N	NONSYN	454	456	ACC	928	930	AAT	240;247;248	A;A;T	240;247;248	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1126	1128	TTG	137;135;134	T,C;T;G	136,1;135;134	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1156	1158	AGC	127;127;127	A;G;C	127;127;127	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1225	1227	CTG	133;132;134	C;T;G,A	133;132;133,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1231	1233	TCC	133;132;132	T,G;C,A;C	131,2;130,2;132	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1246	1248	GTG	143;144;144	G;T,G;G,A	143;143,1;143,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1668	folP	852	852	93.78	folP.l15.c4.ctg.1	1901	109.4	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1297	1299	GCG	183;182;182	G;C,T;G,T	183;181,1;181,1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5004	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3808	163.8	1	SNP	p	S91F	0	.	.	271	273	TCC	786	788	TCC	217;217;215	T;C;C	217;217;215	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5004	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3808	163.8	1	SNP	p	D95N	0	.	.	283	285	GAC	798	800	GAC	221;225;225	G;A;C	221;225;225	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5004	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3808	163.8	1	SNP	p	D95G	0	.	.	283	285	GAC	798	800	GAC	221;225;225	G;A;C	221;225;225	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	531	1830	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1773	128.8	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	994	994	T	196	T,A,C	194,1,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1112	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1440	96.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4548	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3428	165.7	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1691	1693	ATC	213;214;217	A,C;T;C	212,1;214;217	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4548	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3428	165.7	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1844	1846	GCA	208;208;212	G;C;A	208;208;212	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4548	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3428	165.7	1	SNP	p	D86N	0	.	.	256	258	GAC	797	799	GAC	237;236;237	G;A;C	237;236;237	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4548	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3428	165.7	1	SNP	p	S87I	0	.	.	259	261	AGT	800	802	AGT	234;230;231	A,C;G;T,G,C	233,1;230;229,1,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4548	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3428	165.7	1	SNP	p	S87W	0	.	.	259	261	AGT	800	802	AGT	234;230;231	A,C;G;T,G,C	233,1;230;229,1,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4548	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3428	165.7	1	SNP	p	S87R	0	.	.	259	261	AGT	800	802	AGT	234;230;231	A,C;G;T,G,C	233,1;230;229,1,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4548	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3428	165.7	1	SNP	p	S88P	0	.	.	262	264	TCC	803	805	TCC	230;232;230	T;C;C	230;232;230	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4138	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3129	165.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1830	1832	GGC	250;247;245	G,A;G;C	249,1;247;245	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	A502V	1	A502V	NONSYN	1504	1506	GCG	2075	2077	GTG	217;216;216	G,C;T,G;G,A	215,1;215,1;215,1	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1502	1504	GCA	254;254;255	G,T;C;A	253,1;254;255	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1505	1507	ATC	254;251;252	A;T;C,T,A	254;251;250,1,1	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1517	1519	GTG	251;254;255	G,T;T;G	250,1;254;255	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1517	1519	GTG	251;254;255	G,T;T;G	250,1;254;255	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2021	2023	ACC	236;236;234	A;C;C	236;236;234	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2198	2200	GGT	206;205;208	G,T;G;T,G	205,1;205;207,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2207	2209	GGC	209;207;206	G,T;G;C	208,1;207;206	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	539	3936	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2804	175.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2225	2227	CCG	200;199;199	C,G;C;G	199,1;199;199	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5376	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3579	187.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1911	1913	CTG	217;214;212	C;T,G;G	217;213,1;212	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2310	porA	1146	1146	99.74	porA.l15.c17.ctg.1	2280	126.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	640	642	GGC	177;178;178	G,C;G;C	176,1;178;178	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2310	porA	1146	1146	99.74	porA.l15.c17.ctg.1	2280	126.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	822	822	C	188	C	188	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	100	94.0	porB1a.l6.c17.ctg.1	813	25.1	0	.	p	.	0	M18T	NONSYN	52	54	ATG	764	766	ACG	60;59;57	A;C;G	60;59;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	100	94.0	porB1a.l6.c17.ctg.1	813	25.1	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	806	808	CAA	21;19;17	C;A;A	21;19;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	12	14	TTA	23;25;26	T;T;A	23;25;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	51	53	ACT	55;55;55	A;C;T	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	57	59	CAT	55;55;55	C;A;T	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	60	62	AGT	55;55;55	A;G;T	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	69	71	TAC	55;55;55	T;A;C	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	R307A	NONSYN	919	921	AGA	159	161	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	171	173	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	E312D	NONSYN	934	936	GAA	174	176	GAC	1;1;1	G;A;C	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	180	182	ATC	1;1;2	A;T;C	1;1;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	186	188	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	192	194	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	195	197	AGC	2;4;4	A;G;C	2;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	198	200	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	300	porB1a	984	222	90.09	porB1a.l6.c17.ctg.3	388	29.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	204	206	GTT	6;6;6	G;T;T	6;6;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	546	548	GAA	276;274;269	G;A;A	275;273;268	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	834	836	GAT	205;207;206	G,T;A;T,G,A	204,1;207;204,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	957	959	TCA	246;245;249	T;C,T;A	246;244,1;249	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1086	1088	GTC	252;256;255	G;T,G;C	252;255,1;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1206	1208	CAT	265;262;264	C;A;T	265;262;264	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1308	1310	ACT	245;245;246	A;C;T	245;245;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1416	1418	GCA	223;220;222	G;C;A	223;220;222	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	1	SNP	p	G120K	1	.	.	358	360	AAG	792	794	AAG	245;243;241	A,C;A,G;G	244,1;242,1;241	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	1	SNP	p	A121D	1	.	.	361	363	GAC	795	797	GAC	239;240;240	G;A;C	239;240;240	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1643	218.5	1	SNP	p	D121N	0	.	.	361	363	GAC	795	797	GAC	239;240;240	G;A;C	239;240;240	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9966	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5248	236.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2180	2182	CAT	244;244;244	C;A;T	244;244;244	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1544	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1511	127.5	1	SNP	p	V57M	1	.	.	169	171	ATG	840	842	ATG	280;282;281	A;T;G,A	280;282;280,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
